Exploring the impact of stigmatization on mental health in persons with liver disease: a scoping review

ELPA collaborated to draft a new article published in Psychology, Health & Medicine (2026), which highlights the significant impact of stigma on the mental health and quality of life of people living with liver diseases, including hepatitis, cirrhosis, MASLD, and MASH. The study shows that stigma—often driven by misconceptions linking liver disease to personal behaviour or contagion—is strongly associated with depression, anxiety, and reduced quality of life. It also contributes to social isolation, fear of disclosure, and lower engagement with healthcare. Importantly, the research reveals that stigma varies by disease type and demographics, disproportionately affecting marginalised groups, including younger individuals, women, and transgender people. The findings underline the urgent need for patient-centred approaches, including non-stigmatising communication, integrated psychosocial care, and stronger involvement of patient advocacy organisations to address stigma and improve outcomes in liver disease.